Resistance for anti-tuberculosis drugs in Central Black Sea Region of Turkey

• Autorzy: Bilgin S , Unsal M. , Cebi H.H. , Akgunes A.
• Języki publikacji: EN

Abstrakty

EN

One of the primary aims in tuberculosis (TB) management is to detect new cases as early as possible, and instigate the most appropriate therapy, for which it is important to know the characteristics of TB drug resistance in society. The aim of our study was to determine the resistance status of tuberculosis in the Samsun region of Turkey. To achieve that, the medical records of 1,029 pulmonary tuberculosis patients admitted to Samsun Chest Diseases and Chest Surgery Hospital between 2004 and 2006 were analyzed for drug resistance characteristics. In order to define the problem, isolates were tested on Lowenstein-Jensen medium. For drug susceptibility testing, isoni-azid (1), streptomycin (S), ethambutol (E), rifampicin (R) and the radiometric Bactec 460 TB system were used. Eighty-six percent (86%) of the cases (623/721) were new patients, and 13.5% (98/721) were previously treated cases. One hundred and thirty-four (134) of the 721 patients (18.6%) had resistance to one or more drugs. Resistance to any drug was determined in 16.9% (105/623) cases of new patients. I resistance was 13.2%, any R resistance was 2.9%, and multi-drug resistance (MDR) was 1.9%. In previously treated cases, resistance to any drug was 29.6%, any I resistance was 26.5%, any R resistance was 15.3%, and MDR was 13.3%. It was concluded that resistance to anti-tuberculosis drugs is an important problem in Samsun.

Słowa kluczowe

EN

human disease; health problem; tuberculosis; drug resistance; antitubercular drug; Central Black Sea Region; Turkey

• Wydawca: -
• Czasopismo: Polish Journal of Microbiology
• Rocznik: 2010
• Tom: 59
• Numer: 2
• Strony: 125-128
• Opis fizyczny: p.125-128,ref.

Twórcy

autor

Bilgin S

• Ondokuz Mayys University, Samsun, Turkey

autor

Unsal M.

autor

Cebi H.H.

autor

Akgunes A.

Bibliografia

• Ang Ö and M. Uzun. 1998. Latest situation of tuberculosis in Turkey. J. Klimik 11(1): 3-5.
• Arseven O., H. Eraksoy, Y. Uzun, C. Sepkin, A. Kalayciolu, M. Özmenoğlu and O. Bölükbaşi. 1995. Antituberculosis drug resistance in the eastern Black sea Region of Turkey (in Turkish). J. Klimik 8: 63-67.
• Bastian I. and R. Colebunders. 1999. Treatment and prevention of multidrug - resistant tuberculosis. Drugs 58: 633-616.
• Bengisun S.J., D. Karnak, I. Palabiyikodlu and N. Saygun. 2000. Mycobacterium tuberculosis drug resistance in Turkey, 1976-97, 1976-97. Scand. J. Infect. Dis. 32: 507-510.
• Cohn D.L., F. Bustreo and M.C. Raviglione. 1997. Drug-resistant tuberculosis: review of the worldwide situation and the WHO/IUATLD Global Surveillance Project. International Union Against Tuberculosis and Lung Disease. Clin. Infect. Dis: 24 Suppl 1: S121-30.
• Liu C.E., C.H. Chen CH, Hsiao, T.G. Young, R.W. Tsay and C.P. Fung. 2004. Drug resistance of Mycobacterium tuberculosis complex in central Taiwan. J. Microbiol. Immunol. Infect. 37: 295-300.
• Espinal M.A. 2003. The global situation of MDR-TB. Tuberculosis (Edinb). 83: 44-51.
• Gumuslu E, S. Ozkara, S. Ozkan, F. Baykal and U. Gullu. 2007. TB Management report in Turkey (in Turkish). Ankara, Turkey: Department of Tuberculosis Control Ministry of Health.
• Karagoz T, P. Pazarli, O.Y. Mocin, D. Duman, G. Duman, C. Salturk and O. Unal. 2008. Evaluation of drug resistance in pulmonary tuberculosis patients at Sureyyapasa Chest Diseases Hospital, Istanbul, Turkey. The International Journal of Tuberculosis and Lung Disease 12: 631-635.
• Mahmoudi A. and M.D. Iseman. 1993. Pitfalls in the care of patients with tuberculosis. Common errors and their association with the acquisition of drug resistance. JAMA 270: 65-68.
• Mc Cray E., C. Weinbaum and C.R. Braden. 1997. The epidemiology of tuberculosis in the United States. Clin. Chest Med. 18: 99-113.
• Senol G., B. Komurcuoglu and A. Komurcuoglu. 2005. Drug resistance of Mycobacterium tuberculosis in Western Turkey: a retrospective study from 1100-bed teaching hospital. J. Infect. 50: 306-311.
• Siddiqi SH. 1996. Drug susceptibility testing. In: BACTEC TB system product and procedure manual (Revision E). Maryland: BectonDickinson, pp. IV.1-IV.23.
• Storla D.G., Z. Rahim, M.A. Islam, S. Plettner, V. Begum, B. Myrvang, G. Bjune, E. Rønnild, U.R. Dahle and T. Mannsaker. 2007. Drug resistance of Mycobacterium tuberculosis in the Sunamganj District of Bangladesh. Scand. J. Infect. Dis. 39: 142-145.
• Uçan E.S. 1994. Problem of anti-tuberculosis drug resistance in Turkey.J. Tuberc. Tanks 42: 219-225.
• World Health Organization. 2008. Anti-tuberculosis drug resistance in the world: the WHO/IUATLD Global Project on Anti-Tuberculosis Drug Resistance Surveillance. WHO/TB, Geneva.
• W.H.O. Organization. 2007. The Global MDR-TB & XDR-TB response Plan 2007-2008. World.Health Organization Document. WHO/HTM/TB/2007.387.
• Yolsal N., G. Malat, R. Dişçi, M. Orkun and Z. Kilçaslan. 1998. Comparison of tuberculosis drugs resistance problem in years 1984-99 and 1999-94 in years in Turkey. Meta analyze. J. Klimik 11: 6-9.